Cargando…

Additional information gained by positron emission tomography with (68)Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors

OBJECTIVE: Positron emission tomography (PET)/computed tomography (CT) using (68)Ga-labeled 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid-d-Phe(1)-Tyr(3)-octreotide (DOTATOC) has been used to detect neuroendocrine tumors (NETs). The purpose of this study was to investigate the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamoto, Yuji, Sano, Kohei, Ishimori, Takayoshi, Ueda, Masashi, Temma, Takashi, Saji, Hideo, Togashi, Kaori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661205/ https://www.ncbi.nlm.nih.gov/pubmed/25894056 http://dx.doi.org/10.1007/s12149-015-0973-7

Ejemplares similares

Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
por: Schreiter, Nils Friedemann, et al.
Publicado: (2014)

Prospective Analysis of the Impact of (68)Ga-DOTATOC Positron Emission Tomography–Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors
por: Ghobrial, Silvia N., et al.
Publicado: (2020)

Staging of neuroendocrine tumours: comparison of [(68)Ga]DOTATOC multiphase PET/CT and whole-body MRI
por: Schraml, C., et al.
Publicado: (2013)

Meningiomas: A Comparative Study of (68)Ga-DOTATOC, (68)Ga-DOTANOC and (68)Ga-DOTATATE for Molecular Imaging in Mice
por: Soto-Montenegro, María Luisa, et al.
Publicado: (2014)

Prospective data-driven respiratory gating of [(68)Ga]Ga-DOTATOC PET/CT
por: Sigfridsson, Jonathan, et al.
Publicado: (2021)

[(68)Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
por: Gehler, Barbara, et al.
Publicado: (2009)

Pindborg Tumor—An Uncommon Odontogenic Tumor Detected by 68Ga-DOTATOC
por: Herden, Anna, et al.
Publicado: (2022)

Primary phosphaturic mesenchymal tumour of the lumbar spine: utility of (68)Ga-DOTATOC PET/CT findings
por: Maehara, Junki, et al.
Publicado: (2016)

The Dependence of Renal (68)Ga[Ga]-DOTATOC Uptake on Kidney Function and Its Relevance for Peptide Receptor Radionuclide Therapy with (177)Lu[Lu]-DOTATOC
por: Gühne, Falk, et al.
Publicado: (2021)

Role of (68)Ga-DOTATOC PET/CT in the Evaluation of Primary Pulmonary Carcinoids
por: Jindal, Tarun, et al.
Publicado: (2010)

Evaluation of the Possible Utilization of (68)Ga-DOTATOC in Diagnosis of Adenocarcinoma Breast Cancer
por: Zolghadri, Samaneh, et al.
Publicado: (2018)

Artificial intelligence-based (68)Ga-DOTATOC PET denoising for optimizing (68)Ge/(68)Ga generator use throughout its lifetime
por: Quak, Elske, et al.
Publicado: (2023)

Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
por: Thuillier, Philippe, et al.
Publicado: (2021)

[(68)Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [(177)Lu]DOTATOC PRRT: The “Theragnomics” Concept
por: Laudicella, Riccardo, et al.
Publicado: (2022)

Effective localization in tumor-induced osteomalacia using (68)Ga-DOTATOC-PET/CT, venous sampling and 3T-MRI
por: Kawai, Shintaro, et al.
Publicado: (2017)

Usefulness of (68)Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia
por: Lee, Dong Yun, et al.
Publicado: (2021)

Thyroid metastasis from lung carcinoid detected by (68)Ga-DOTATOC PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

(68)Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
por: Boughdad, Sarah, et al.
Publicado: (2021)

Splenosis Mimicking Relapse of a Neuroendocrine Tumor at Gallium-68-DOTATOC PET/CT
por: Treglia, Giorgio, et al.
Publicado: (2013)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
por: Mapelli, Paola, et al.
Publicado: (2021)

68Ga-DOTA-D Phe1-Tyr3-Octreotide (DOTATOC)-PET/CT in a Suspected Case of Recurrent Meningioma
por: Jain, Sachin, et al.
Publicado: (2017)

Relevance of Volumetric Parameters Applied to [(68)Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT
por: Urso, Luca, et al.
Publicado: (2023)

A Rare Case of Incidental Finding of Cervical Spinal Cord Hemangioblastoma by (68)Ga-DOTATOC Positron Emission Tomography/Computed Tomography Scan
por: Bellini, Pietro, et al.
Publicado: (2022)

Detection of neuroendocrine tumours in the small intestines using contrast-enhanced multiphase Ga-68 DOTATOC PET/CT: the potential role of arterial hyperperfusion
por: Schreiter, Nils F., et al.
Publicado: (2014)

Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review
por: Lancellotti, Francesco, et al.
Publicado: (2019)

Correction: (68)Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
Publicado: (2022)

Optic Nerve Sheath Meningiomas: Solving Diagnostic Challenges with (68)Ga-DOTATOC PET/CT
por: Horowitz, Tatiana, et al.
Publicado: (2023)

Diagnostic Impact of Dual-Time PET/CT with (68)Gallium-PSMA in Prostate Cancer and (68)Gallium-DOTATOC in Neuroendocrine Tumors
por: Librizzi, Damiano, et al.
Publicado: (2023)

Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT
por: Durmo, Rexhep, et al.
Publicado: (2022)

Comparison of diagnostic value of 68 Ga-DOTATOC PET/MRI and standalone MRI for the detection of intracranial meningiomas
por: Einhellig, Heike C., et al.
Publicado: (2021)

The utility of gallium-68 DOTATOC PET/CT in lymphangioleiomyomatosis
por: Gaffney, Brian, et al.
Publicado: (2021)

Functional Imaging of Pheochromocytoma with (68)Ga-DOTATOC and (68)C-HED in a Genetically Defined Rat Model of Multiple Endocrine Neoplasia
por: Miederer, Matthias, et al.
Publicado: (2011)

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from (68)Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
por: Weber, Manuel, et al.
Publicado: (2020)

Preclinical Study of (68)Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
por: Naderi, Mojdeh, et al.
Publicado: (2016)

(68)Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination
por: Boursier, Caroline, et al.
Publicado: (2021)

Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma
por: Iglseder, Sarah, et al.
Publicado: (2023)

First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [(18)F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas
por: Fujimoto, Hiroyuki, et al.
Publicado: (2021)

THU036 (68)Ga-DOTATOC PET/CT In Localization Of ACTH-producing Pituitary Tumors In Patients With Cushing Disease
por: Kim, Kyungwon
Publicado: (2023)

Diagnostic performance of a whole-body dynamic (68)GA-DOTATOC PET/CT acquisition to differentiate physiological uptake of pancreatic uncinate process from pancreatic neuroendocrine tumor
por: Thuillier, Philippe, et al.
Publicado: (2020)

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by (68)Ga-DOTATOC PET/CT
por: Jahn, Ulrika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ctlcstng9dcv1oipmtqmskg1ps